glp-1 drugs and parkinson's disease Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease | Journal of Biomedical Science The glucagon-like peptide 1 (GLP)
Description
2021;161(6):184252 e10
Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis
GLP-1s are powerful tools, but theyre not magic pills
[DOI] [PubMed] [Google Scholar] 37.De Bernardinis M, Violi V, Roncoroni L, Boselli AS, Giunta A, Peracchia A
Mathur, R., Alexander, C
